Accessibility Menu
Omada Health logo

Omada Health(NASDAQ) OMDA

Current Price$20.57
Market Cap$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-11%
5 YearN/A
1 Year+9%
1 Month+10%
Omada Health last closing stock price
MetricPriceDate
Last closeUSD 20.532026-07-24
Omada Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.38%USD 23.702026-07-17
1 month+10.38%USD 18.602026-06-24
3 month+43.27%USD 14.332026-04-24
Year to date+30.1%USD 15.782025-12-31
1 year+8.8%USD 18.872025-07-24
Since inception-10.74%USD 23.002025-06-06

Omada Health Financials at a Glance

Market Cap

$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$283.30M

Net Income (TTM)

-$6.30M

EPS (TTM)

-$0.11

P/E Ratio

-187.32

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$20.57

Volume

1,224,932.112

Open

$21.50

Previous Close

$20.53

Daily Range

$20.51 - $21.60

52-Week Range

$10.28 - $26.92

Estimated Earnings Date

Aug 6, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Omada Health

Omada Health helps people manage long-term health issues from home. It connects patients with digital tools and personal health coaches. Companies and insurance providers pay for these services for members.

The Virtual Health Toolkit

  • Cardiometabolic Programs: Support for individuals with prediabetes, diabetes, and high blood pressure through behavior change and connected devices.
  • Musculoskeletal Care: Virtual physical therapy for joint and muscle pain using video visits and motion-tracking technology.
  • GLP-1 Care Track: Specialized weight management support for members using glucagon-like peptide-1 agonists (GLP-1) weight-loss medications.
  • Prevention and Weight: Behavior change programs focused on nutrition and exercise to reduce the risk of chronic disease.

Recent Strategic Shifts

  • Introduced the GLP-1 Care Track in 2023 to support members on newer weight-loss drug therapies.
  • Expanded into physical therapy services with the launch of Omada for MSK in 2020.
  • Announced plans to launch direct prescription capabilities for anti-obesity medications in 2026.
  • Established the Omada Insights Lab to use internal data for improving clinical outcomes and member experiences.

What Makes Them Different

The company uses a system called Compassionate Intelligence to combine human coaching with machine learning and automated data analysis. This platform integrates real-time data from cellular-connected scales and blood sugar monitors to personalize care plans for members between doctor visits.

Tracking Recent Performance

  • Revenue reached $75.8 million in Q4 2025, a 58.1% increase from $48 million in Q4 2024.
  • Net income turned positive at $5.2 million in Q4 2025, up from an $8.2 million loss in Q4 2024.
  • Free cash flow hit $21.2 million in Q4 2025, compared to a $7.5 million loss the previous year.
  • The company had 886,000 enrolled members across more than 2,000 customers as of December 31, 2025.

The Big Picture

Omada Health has transitioned from a single-focus diabetes prevention app into a broad provider of virtual chronic care. Its shift toward direct medication management and clinical integration reflects an evolving role in the modern healthcare market.

AI Generated • May 2, 2026

Industry

Healthcare Providers and Services

Employees

916

CEO

Sean Duffy, MD, MBA

Headquarters

San Francisco, CA 94111, US

OMDA Financials

Key Financial Metrics (TTM)

Gross Margin

66.22%

Operating Margin

-2.95%

Net Income Margin

-2.22%

Return on Equity

-2.81%

Return on Capital

-5.21%

Return on Assets

-2.08%

Earnings Yield

-0.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

59.45M

Volume

1.22M

Avg. Volume

1.18M

Financials (TTM)

Gross Profit

$187.61M

Operating Income

-$8.36M

EBITDA

$491.00K

Operating Cash Flow

$22.54M

Capital Expenditure

-$3.51M

Free Cash Flow

$19.02M

Cash & ST Invst.

$211.77M

Total Debt

$0.00

Omada Health Performance Analysis

Omada Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 89,185,000N/A
20232023-12-31USD 122,784,00037.7%
20242024-12-31USD 169,800,00038.3%
20252025-12-31USD 260,210,00053.2%
Omada Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3011.7%
Q32025-09-3010.9%
Q42025-12-3111.5%
Q12026-03-312.9%
Omada Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.30N/A
20232023-12-31USD -1.21-6.9%
20242024-12-31USD -0.85-30.2%
20252025-12-31USD -0.22-74.1%
Omada Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3045.5%
Q32025-09-3040.7%
Q42025-12-31260.8%
Q12026-03-31-157.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$78.05M

+42.0%

Gross Profit

$48.69M

+52.6%

Gross Margin

62.39%

N/A

Market Cap

$1.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.44M

N/A

Employees

849

N/A

Net Income

-$2.97M

+68.6%

EBITDA

-$1.44M

+79.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$211.77M

+256.5%

Total Debt

$0.00

-100.0%

Accounts Receivable

$39.99M

+36.6%

Inventory

$3.83M

+25.9%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.08%

N/A

Return on Invested Capital

-3.57%

N/A

Free Cash Flow

-$11.91M

+31.4%

Operating Cash Flow

-$11.83M

+26.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SDGRSchrödinger, Inc.
$14.97-1.06%
XERSXeris Biopharma Holdings, Inc.
$8.32-1.07%
MAZEMaze Therapeutics, Inc.
$27.68-0.04%
TDOCTeladoc Health, Inc.
$8.77+1.27%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About OMDA

What is the current price of Omada Health?

Omada Health is trading at $20.53 per share.

What is the 52-week range for Omada Health?

Over the past 52 weeks, Omada Health has traded between $10.28 and $26.92.

How much debt does Omada Health have?

As of the most recent reporting period, Omada Health reported total debt of $0.00.

How much cash does Omada Health have on hand?

Omada Health reported $211.77M in cash and cash equivalents in its most recent financial results.

What is Omada Health’s dividend yield?

Omada Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.